These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 37034380)

  • 21. Rifle Blast Exacerbating Hearing Loss in a Patient Treated With Teprotumumab for Thyroid Eye Disease.
    Reed DS; Kostosky N; Davies BW; Epstein A; Durairaj VD
    Ophthalmic Plast Reconstr Surg; 2022 Mar-Apr 01; 38(2):e41-e43. PubMed ID: 34652314
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Refractory Thyroid Eye Disease Unresponsive to Teprotumumab: A Case Report.
    Singh G; Taylor B; Michalek S
    Cureus; 2023 Nov; 15(11):e48861. PubMed ID: 38111423
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oral steroid regimens for idiopathic sudden sensorineural hearing loss.
    Slattery WH; Fisher LM; Iqbal Z; Liu N
    Otolaryngol Head Neck Surg; 2005 Jan; 132(1):5-10. PubMed ID: 15632902
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Teprotumumab for Treatment of Pretibial Myxedema.
    Reyes MP; Cabrera J; Singh J; Turnbull D
    JCEM Case Rep; 2023 Jan; 1(1):luac037. PubMed ID: 37908268
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Teprotumumab for the treatment of thyroid eye disease.
    Ju Y; Yang J
    Expert Rev Clin Immunol; 2020 Aug; 16(8):739-743. PubMed ID: 32707005
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Teprotumumab Related Hearing Loss: A Large-Scale Analysis and Review of Voluntarily Reported Patient Complaints to the Food and Drug Administration (FDA).
    McGwin G; Owsley C; Vicinanzo MG
    Ophthalmic Plast Reconstr Surg; 2024 May; ():. PubMed ID: 38771914
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Severe Hyperglycemia with Teprotumumab for Treatment of Thyroid Eye Disease.
    Cottom S; Barrientez B; Melson A
    Case Rep Ophthalmol; 2024; 15(1):246-249. PubMed ID: 38504670
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of Oral Steroids Combined with Postauricular Steroid Injection on Patients with Sudden Sensorineural Hearing Loss with Delaying Intervention: A Retrospective Analysis.
    Liu ZB; Zhu WY; Fei B; Lv LY
    Niger J Clin Pract; 2023 Jun; 26(6):760-764. PubMed ID: 37470650
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oral vs intratympanic corticosteroid therapy for idiopathic sudden sensorineural hearing loss: a randomized trial.
    Rauch SD; Halpin CF; Antonelli PJ; Babu S; Carey JP; Gantz BJ; Goebel JA; Hammerschlag PE; Harris JP; Isaacson B; Lee D; Linstrom CJ; Parnes LS; Shi H; Slattery WH; Telian SA; Vrabec JT; Reda DJ
    JAMA; 2011 May; 305(20):2071-9. PubMed ID: 21610239
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Teprotumumab for the Treatment of Active Thyroid Eye Disease.
    Douglas RS; Kahaly GJ; Patel A; Sile S; Thompson EHZ; Perdok R; Fleming JC; Fowler BT; Marcocci C; Marinò M; Antonelli A; Dailey R; Harris GJ; Eckstein A; Schiffman J; Tang R; Nelson C; Salvi M; Wester S; Sherman JW; Vescio T; Holt RJ; Smith TJ
    N Engl J Med; 2020 Jan; 382(4):341-352. PubMed ID: 31971679
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Teprotumumab: Interpreting the Clinical Trials in the Context of Thyroid Eye Disease Pathogenesis and Current Therapies.
    Winn BJ; Kersten RC
    Ophthalmology; 2021 Nov; 128(11):1627-1651. PubMed ID: 33930408
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Teprotumumab Efficacy, Safety, and Durability in Longer-Duration Thyroid Eye Disease and Re-treatment: OPTIC-X Study.
    Douglas RS; Kahaly GJ; Ugradar S; Elflein H; Ponto KA; Fowler BT; Dailey R; Harris GJ; Schiffman J; Tang R; Wester S; Jain AP; Marcocci C; Marinò M; Antonelli A; Eckstein A; Führer-Sakel D; Salvi M; Sile S; Francis-Sedlak M; Holt RJ; Smith TJ
    Ophthalmology; 2022 Apr; 129(4):438-449. PubMed ID: 34688699
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sudden-Onset Sensorineural Hearing Loss and Tinnitus in a Patient With Rheumatoid Arthritis: A Case Report and Literature Review.
    Torere BE; Chittipolu S; Alugba G; Aiwuyo HO; Kennard JL
    Cureus; 2023 May; 15(5):e38739. PubMed ID: 37292546
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Early efficacy of teprotumumab for the treatment of dysthyroid optic neuropathy: A multicenter study.
    Sears CM; Wang Y; Bailey LA; Turbin R; Subramanian PS; Douglas R; Cockerham K; Kossler AL
    Am J Ophthalmol Case Rep; 2021 Sep; 23():101111. PubMed ID: 34113737
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Successful treatment of sudden sensorineural hearing loss by means of pharmacotherapy combined with early hyperbaric oxygen therapy: Case report.
    Olex-Zarychta D
    Medicine (Baltimore); 2017 Dec; 96(51):e9397. PubMed ID: 29390550
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Side Effects and Adverse Events After Treatment With Teprotumumab for Thyroid Eye Disease: A Retrospective Observational Case Series.
    Mukit FA; Manley A; Patel AB; Hashemi M; Laplant JF; Fleming JC; Fowler BT
    Cureus; 2024 Apr; 16(4):e58585. PubMed ID: 38765324
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Teprotumumab-trbw as a Novel Monoclonal Antibody for Thyroid Eye Disease: A Literature Review.
    Bocklud BE; Fakhre W; Murphy B; Maddox K; Ahmadzadeh S; Viswanath O; Varrassi G; Shekoohi S; Kaye AD
    Cureus; 2023 Aug; 15(8):e43878. PubMed ID: 37746376
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tinnitus as a prognostic sign in idiopathic sudden sensorineural hearing loss.
    Ben-David J; Luntz M; Magamsa I; Fradis M; Sabo E; Podoshin L
    Int Tinnitus J; 2001; 7(1):62-4. PubMed ID: 14964958
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Coronavirus disease 2019 and sudden sensorineural hearing loss.
    Lang B; Hintze J; Conlon B
    J Laryngol Otol; 2020 Oct; ():1-3. PubMed ID: 33000716
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-Term Follow-Up of a Case of Severe Hyperglycemia Requiring Hospitalization after Third Dose of Teprotumumab: A Case Report.
    Mehta P; Angell T; LeTran V; Lin M; Nguyen A; Zhang-Nunes S
    Case Rep Ophthalmol; 2024; 15(1):115-121. PubMed ID: 38318283
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.